Your browser doesn't support javascript.
loading
COVID-19 in two severe asthmatics receiving benralizumab: busting the eosinophilia myth.
Renner, Andreas; Marth, Katharina; Patocka, Karin; Idzko, Marco; Pohl, Wolfgang.
Afiliação
  • Renner A; Karl Landsteiner Institute for Clinical and Experimental Pneumology, Hietzing Hospital, Vienna, Austria.
  • Marth K; Karl Landsteiner Institute for Clinical and Experimental Pneumology, Hietzing Hospital, Vienna, Austria.
  • Patocka K; Karl Landsteiner Institute for Clinical and Experimental Pneumology, Hietzing Hospital, Vienna, Austria.
  • Idzko M; Dept of Pulmonology, Medical University of Vienna, Vienna, Austria.
  • Pohl W; Karl Landsteiner Institute for Clinical and Experimental Pneumology, Hietzing Hospital, Vienna, Austria.
ERJ Open Res ; 6(4)2020 Oct.
Article em En | MEDLINE | ID: mdl-33257916
ABSTRACT
Experience with very mild #COVID19 disease courses in two severe eosinophilic asthmatics with complete eosinophil depletion due to benralizumab treatment counters the recent theories that eosinophilia is protective in COVID-19 infections https//bit.ly/3cnEFvg.
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: ERJ Open Res Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: ERJ Open Res Ano de publicação: 2020 Tipo de documento: Article